US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

AZN AstraZeneca PLC

78.88

0.32 (0.41%)

21 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

AstraZeneca (NASDAQ:AZN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas AstraZeneca.

AstraZeneca (NASDAQ:AZN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas AstraZeneca.

Noticias sobre AstraZeneca PLC AZN

IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer
Lunes 17 de Junio 2024 (6 días hace) • Business Wire

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
Domingo 16 de Junio 2024 (1 semana hace) • Business Wire

FARXIGA approved in the US for the treatment of pediatric type-2 diabetes
Miércoles 12 de Junio 2024 (2 semanas hace) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Miércoles 12 de Junio 2024 (2 semanas hace) • Edgar (US Regulatory)

TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Lunes 10 de Junio 2024 (2 semanas hace) • Business Wire

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Jueves 6 de Junio 2024 (2 semanas hace) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 4 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Martes 4 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Economic Worries May Lead To Weakness On Wall Street
Martes 4 de Junio 2024 (3 semanas hace) • IH Market News

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
Martes 4 de Junio 2024 (3 semanas hace) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 3 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 3 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Más de AstraZeneca PLC Artículos de Noticias

NLBNPIT21142 20991231 42...

Mitsu Hc Cap 26

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones